Beyond Air, Inc. (XAIR)
Oxford Ledge is still expanding full research coverage of XAIR. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Beyond Air develops nitric oxide generation devices and delivery systems for treating respiratory conditions in newborns and exploring applications in lung infections and other diseases.
SEC filings
- 8-K 3.03; Amendments to articles or bylaws; Financial statements and exhibits 2026-07-09
- 8-K Results of operations / financial condition; Amendments to articles or bylaws; Regulation FD disclosure; Financial statements and exhibits 2026-06-26
- 10-K Annual financial report with audited statements 2026-06-26
- 8-K Shareholder vote results; Other material event 2026-06-22
- 8-K Other material event; Financial statements and exhibits 2026-06-01
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for XAIR. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open XAIR in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.